TY101

· Tayu Huaxia Biotech Medical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TY101, covering 2021-08-13 to 2021-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas [Phase 1, Phase 2]

See pricing